Pemrydi Rtu — pemetrexed RTU
Named-patient access overview. Pemrydi Rtu is coordinated by Reserve Meds for international patients via physician-led cross-border sourcing.
About Pemrydi Rtu
Pemrydi RTU (pemetrexed RTU) is manufactured by Eagle Pharmaceuticals and indicated for NSCLC. It is a unverified approved by the US FDA in unverified and may be accessible to international patients through Named Patient Program or personal-import pathways.
How Reserve Meds coordinates Pemrydi Rtu
- Patient or treating physician submits a named-patient request.
- Clinical team verifies appropriateness of Pemrydi Rtu for the patient and destination country.
- Treating physician issues prescription and clinical justification.
- Country-specific NPP / personal-import documentation is prepared.
- Pemrydi Rtu is sourced from a DSCSA-compliant US specialty wholesaler with full serial traceability.
- Shipment is coordinated to the patient's physician or hospital pharmacy (cold-chain where required).
Access by country
We have documented named-patient access pathways for Pemrydi Rtu in the countries below. Each page outlines the destination-country regulatory posture, typical timeline, and physician-credential requirements.
Pemrydi Rtu in BahrainNamed-patient access, timeline, and regulatory notes
Pemrydi Rtu in IndiaNamed-patient access, timeline, and regulatory notes
Pemrydi Rtu in JordanNamed-patient access, timeline, and regulatory notes
Pemrydi Rtu in KuwaitNamed-patient access, timeline, and regulatory notes
Pemrydi Rtu in PakistanNamed-patient access, timeline, and regulatory notes
Pemrydi Rtu in QatarNamed-patient access, timeline, and regulatory notes
Pemrydi Rtu in Sri LankaNamed-patient access, timeline, and regulatory notes
Start a request for Pemrydi Rtu
Submit a 60-second intake. Our clinical team responds within one business day with case-specific feasibility, timeline, and a formal quote.